(19)
(11) EP 4 798 711 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24795222.9

(22) Date of filing: 28.10.2024
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/1135; C12N 2310/14; C12N 2320/31; C12N 2320/34
(86) International application number:
PCT/EP2024/080487
(87) International publication number:
WO 2025/088215 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 27.10.2023 WO PCT/EP2023/080145

(71) Applicant: The Francis Crick Institute Limited
London, Greater London NW1 1AT (GB)

(72) Inventors:
  • BRYANT, Dale
    London Greater London NW1 1AT (GB)
  • KINSLER, Veronica Anne
    London Greater London NW1 1AT (GB)

(74) Representative: Leonard, Thomas Charles et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) METHODS OF TREATMENT OF MELANOCYTIC DISEASE